170 related articles for article (PubMed ID: 23359473)
1. Impact of serum vascular endothelial growth factor on prognosis in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization.
Guo JH; Zhu X; Li XT; Yang RJ
Chin J Cancer Res; 2012 Mar; 24(1):36-43. PubMed ID: 23359473
[TBL] [Abstract][Full Text] [Related]
2. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
3. High serum levels of vascular endothelial growth factor predict poor response to transarterial chemoembolization in hepatocellular carcinoma: a prospective study.
Poon RT; Lau C; Yu WC; Fan ST; Wong J
Oncol Rep; 2004 May; 11(5):1077-84. PubMed ID: 15069550
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of serum HIF-1α change following transarterial chemoembolization in hepatocellular carcinoma.
Lin ZH; Jiang JR; Ma XK; Chen J; Li HP; Li X; Wu XY; Huang MS; Lin Q
Clin Exp Med; 2021 Feb; 21(1):109-120. PubMed ID: 33037574
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of vascular endothelial growth factor in both conventional and drug eluting beads transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma in HCV patients.
Farid K; Elalfy H; Abo El-Khair SM; Elgamal H; Besheer T; Elmokadem A; Shabana W; Abed S; Elegezy M; El-Khalek AA; El-Morsy A; Negm A; Elsamanoudy AZ; El Deek B; Amer T; El-Bendary M
Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1203-1214. PubMed ID: 32933325
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients.
Ranieri G; Ammendola M; Marech I; Laterza A; Abbate I; Oakley C; Vacca A; Sacco R; Gadaleta CD
World J Gastroenterol; 2015 May; 21(19):6018-25. PubMed ID: 26019468
[TBL] [Abstract][Full Text] [Related]
7. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
Hsieh MY; Lin ZY; Chuang WL
Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
[TBL] [Abstract][Full Text] [Related]
8. Preintervention MCP-1 serum levels as an early predictive marker of tumor response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
You R; Jiang H; Xu Q; Yin G
Transl Cancer Res; 2021 Feb; 10(2):966-976. PubMed ID: 35116424
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of preoperative serum ferritin in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Fan M; Niu T; Lin B; Gao F; Tan B; Du X
Mol Clin Oncol; 2024 Mar; 20(3):22. PubMed ID: 38357673
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implication of serum vascular endothelial growth factor in advanced hepatocellular carcinoma staging.
Yegin EG; Siykhymbayev A; Eren F; Bekiroglu N; Ozdogan OC
Ann Hepatol; 2013; 12(6):915-25. PubMed ID: 24114822
[TBL] [Abstract][Full Text] [Related]
11. Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level.
Li X; Feng GS; Zheng CS; Zhuo CK; Liu X
World J Gastroenterol; 2004 Oct; 10(19):2878-82. PubMed ID: 15334691
[TBL] [Abstract][Full Text] [Related]
12. Cytokines are associated with postembolization fever and survival in hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization.
Chao Y; Wu CY; Kuo CY; Wang JP; Luo JC; Kao CH; Lee RC; Lee WP; Li CP
Hepatol Int; 2013 Jul; 7(3):883-92. PubMed ID: 26201926
[TBL] [Abstract][Full Text] [Related]
13. The effect of doxorubicin on the changes of serum vascular endothelial growth factor (VEGF) in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization (TACE).
Leelawat K; Laisupasin P; Kiatdilokrut A; Pongtongpool T; Narong S; Samkhumphim N; Ket-Horm S
J Med Assoc Thai; 2008 Oct; 91(10):1539-43. PubMed ID: 18972897
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of lenvatinib combined with sequential transarterial chemoembolization for primary hepatocellular carcinoma and the effects on serum basic fibroblast growth factor and vascular endothelial growth factor.
Xie QY; Huang LP; Gao FW; Liu DQ; Wang X; Jiang KY; Gong J; Zhao X; Gao BJ; Lei ZH
Front Pharmacol; 2022; 13():965770. PubMed ID: 36339553
[No Abstract] [Full Text] [Related]
16. Impact of Different Embolic Agents for Transarterial Chemoembolization (TACE) Procedures on Systemic Vascular Endothelial Growth Factor (VEGF) Levels.
Schicho A; Hellerbrand C; Krüger K; Beyer LP; Wohlgemuth W; Niessen C; Hohenstein E; Stroszczynski C; Pereira PL; Wiggermann P
J Clin Transl Hepatol; 2016 Dec; 4(4):288-292. PubMed ID: 28097096
[No Abstract] [Full Text] [Related]
17. Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma.
Poon RT; Ho JW; Tong CS; Lau C; Ng IO; Fan ST
Br J Surg; 2004 Oct; 91(10):1354-60. PubMed ID: 15376182
[TBL] [Abstract][Full Text] [Related]
18. Serum vascular endothelial growth factor per platelet count in hepatocellular carcinoma: correlations with clinical parameters and survival.
Kim SJ; Choi IK; Park KH; Yoon SY; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Jpn J Clin Oncol; 2004 Apr; 34(4):184-90. PubMed ID: 15121753
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic significance of serum level of vascular endothelial growth factor receptor-2 in hepatocellular carcinoma patients after transcatheter arterial chemoembolization].
Meng QW; Li Y; Hu BS; Shao PJ; Zhan MX; Yu XY; Lu LG
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(5):341-4. PubMed ID: 23660204
[TBL] [Abstract][Full Text] [Related]
20. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma].
Zhao J; Hu J; Cai J
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):389-92. PubMed ID: 11810769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
